KISS1 and hypoalphalipoproteinemia, primary, 1: Jayasena et al. [26] published that subcutaneous injection of kisspeptin was able to induce gonadotropin secretion as well as estradiol rise in women suffering for FHA thus supporting the hypothesis that kisspeptin stimulates gonadotropins release and that its one of the neurohormones driving reproduction [17].